ABSTRACT. Osteoporosis is a common disease in the aging population and studies have shown that interleukin-6 (IL-6) is potentially implicated in its pathogenesis. This study was designed to assess the association between the IL-6 gene -634C/G polymorphism and osteoporosis. PubMed, Embase, China National Knowledge Infrastructure, and Wanfang databases were searched for eligible studies published up to and including December 2014 in English or Chinese. Meta-analysis was conducted by the RevMan5.2 software. Weighted mean difference and 95% confidence interval (95%CI) were calculated by a fixed-effect or random-effect model. Bone mineral density (BMD) was regarded as the assessment index. As a result, a total of four articles with 3068 subjects were included. Differences in BMD between the CC and GG genotypes were 0.03 g/cm 2 (95%CI = 0.01 to 0.05) at total body, 0.01 g/cm 2 (95%CI = 0.00 to 0.03) at femoral neck, and 0.03 g/cm 2 (95%CI = 0.00 to 0.06) at the lumbar spine (P < 0.05). For the CG versus GG genotypes, the differences in BMD were 0.03 g/cm 2 (95%CI = 0.02 to 0.05) at total body and 0.02 g/cm 2 (95%CI = 0.00 to 0.03 at the femoral neck (P < 0.05). For the CC versus CG genotypes, the differences in BMD were not significant (P > 0.05). In conclusion, the GG genotype of L. Yan et al.
INTRODUCTION
Osteoporosis (OP) is a metabolic bone disease characterized by increased bone fragility and susceptibility to fracture, which is due to bone mineral content loss and microstructure disorder (Adams, 2013) . OP is the outcome of the combined action of multiple factors, including heredity, nutrition, lifestyle, and hormones (Willson et al., 2015) . However, the molecular pathogenesis has not been fully elucidated.
Seventy percent of OP cases are determined by genetic factors that affect bone turnover and bone mineral density (BMD) (Pocock et al., 1987) . These factors include the estradiol receptor, the calcitonin receptor, interleukin-6 (IL-6) and parathyroid hormone (PTH) (Al-Daghri et al., 2014) . Therefore, determining the relationship between these cytokines and OP is necessary to explore the pathogenesis of OP. Recent studies have shown that IL-6 can regulate the proliferation, differentiation, and apoptosis of osteoblasts through various pathways (Kaneshiro et al., 2014) . For postmenopausal women, the decrease in the level of estrogen may trigger the expression of IL-6, which has been shown to result in bone resorption. When bone resorption exceeds bone formation, OP can commence (Erices et al., 2002) . Scheidt et al. (2001) found that IL-6 was one of the main factors to predict bone loss. IL-6 is a multifunctional cytokine regulating immune reactions (Kosa et al., 2009) , bone resorption (Nakamura et al., 2014) , and osteoarthritis (Valdes et al., 2010) . The -174G/C and -634C/G (rs1800796) single nucleotide polymorphisms (SNPs) in the IL-6 gene were found to be associated with IL-6 promoter activity and were significantly associated with BMD (Oishi et al., 2012) . Since OP is commonly characterized by lower BMD (Senn et al., 2014) , the purpose of this study was to evaluate the correlation between the IL-6 -634C/G polymorphism and risk of OP by meta-analysis.
MATERIAL AND METHODS

Literature retrieval
The PubMed, Embase, China National Knowledge Infrastructure (CNKI), and Wanfang databases were searched for eligible studies published from January 2000 to December 2014, with no language restrictions and the subject terms as "bone", "bone mineral density", "interleukin-6", "polymorphism", and "-634C/G". The potential relevant articles were screened by reading titles and abstracts. A full-text review was undertaken to filter for subsequent studies.
Inclusion and exclusion criteria
Inclusion criteria included the following: 1) sufficient information that the -634C/G genotype was exhibited in OP patients; and 2) BMD value at total body, femoral neck, lumbar spine, and distal radius was shown by genotype. Exclusion criteria were as follows: 1) studies that did not include the -634C/G polymorphism; 2) study that did not concern OP; 3) studies with subjects under 15 years of age; and 4) studies with unclear genotype data.
Data extraction
Two investigators (L. Yan and R. Hu) independently extracted the data, including authors, journal, publication year, population location, sample size, age, gender, menopausal status, and genotype information. The mean BMD values and standard deviation for each genotype at total body, femoral neck, lumbar spine, and distal radius were recorded. When there were conflicting evaluations, an agreement was reached after a discussion. If data were missing in the paper, the corresponding authors were contacted in order to obtain missing data. The articles with unavailable data were excluded from the study.
Literature quality assessment
The same two investigators (L. Yan and R. Hu) independently assessed the quality of the studies. Using grading standards modified from Thakkinstian et al. (2004) (Table 1 ), the quality scores were calculated. Total scores ranged from 0, being the worst, to 9, being the best. When scores were less than 6, the study was considered to be of low quality; studies with a score higher than 6 were ranked as high quality. IL-6, interleukin-6; BMD, bone mineral density; DXA, dual-energy X-ray absorptiometry; HWE, Hardy-Weinberg equilibrium. The scores are used to assess the methodological quality of the included studies.
Statistical analysis
The main analysis addressed differences in BMD between different genotypes. Genotypes were assessed as CC vs CG, CC vs GG, and CG vs GG. Heterogeneity between studies was evaluated by the χ 2 test and P < 0.05 was considered to be significant (Bowden et al., 2011) . Heterogeneity was also assessed by the I 2 metric, which was considered to be significant for I 2 > 50%. When heterogeneity was absent, a fixed-effect model was used to pool results from individual studies; otherwise, a random-effect model was used. The Z-test was used to assess the significance of the pooled weighted mean difference (WMD) and P < 0.05 was considered to be significant.
RESULTS
Characteristics of eligible studies
A total of four articles (Ota et al., 2001; Yamada et al., 2003; Li et al., 2008; Oishi et al., 2012) with 3068 subjects were included in this study (Figure 1 ) and the characteristics are summarized in Table 2 . All the subjects were Asian and 1942 were women and 1126 were men. Of the women, 176 subjects were premenarche, 379 subjects were premenopausal and 1387 subjects were postmenopausal. The BMD values of total body, femoral neck, lumbar spine, and distal radius in relation to the IL-6 gene -634C/G polymorphism were analyzed. Quality score was obtained according to the criteria of methodological quality assessment for eligible studies, and it represents the quality of the study included.
Association between the -634C/G IL-6 polymorphism and BMD
For CC vs CG genotypes, there was no difference in BMD of the total body (Z = 0.48, P = 0.63), femoral neck (Z = 0.13, P = 0.90), lumbar spine (Z = 0.82, P = 0.41), and distal radius (Z = 1.62, P = 0.11). For CC vs GG genotypes, there was an obvious difference in BMD of the total body (Z = 3.26, P = 0.001), femoral neck (Z = 2.08, P = 0.04), and lumbar spine (Z = 2.00, P = 0.05) (Figure 2) . However, there was no significant difference in the distal radius (Z = 1.09, P = 0.28). The differences in BMD between the CC and GG genotypes were 0.03 g/cm 2 (95%CI = 0.01 to 0.05) of the total body, 0.01 g/cm 2 (95%CI = 0.00 to 0.03) the femoral neck, and 0.03 g/cm 2 (95%CI = 0.00 to 0.06) the lumbar spine. For CG vs GG genotypes, there was also a difference in BMD of the total body (Z = 3.89, P = 0.0001) and femoral neck (Z = 2.45, P = 0.01) (Figure 3 ), but no significant difference for the lumbar spine (Z = 1.81, P = 0.07) or distal radius (Z = 0.64, P = 0.52). The differences in BMD were 0.03 g/cm 2 (95%CI = 0.02 to 0.05) for the total body and 0.02 g/cm 2 (95%CI = 0.00 to 0.03) for the femoral neck (P < 0.05). 
Sensitivity and publication bias diagnosis
Sensitivity analysis confirmed the stability of the association between the -634C/G polymorphism in IL-6 and BMD at the total body, femoral neck, and lumbar spine and no publication bias was detected in the studies included.
DISCUSSION
OP has been shown to be a multifactorial disease with strong genetic influence. Studies on the candidate genes of OP mainly focus on the vitamin D receptor (VDR), calcitonin receptor, estrogen receptor, IL-6 and type I collagen (COLIA1) genes (Clark and Duncan, 2015) . Among the various cytokines affecting bone metabolism, IL-6 plays an important role in osteoclast differentiation and maturation.
This study conducted a comprehensive analysis of literature to assess the association between the IL-6 gene -634C/G polymorphism and BMD in different areas of the body (total body, femoral neck, lumbar spine, and distal radius). The results indicate that the differences in BMD between the CC and GG genotypes of the total body, femoral neck, and lumbar spine were of statistical significance. For the CG versus GG genotypes, the differences in BMD at the total body and femoral neck were significant. For the CC versus CG genotypes, the differences in BMD were not significant. The G allele increased the risk of osteoporosis and many other studies have shown similar data (Ota et al., 2001; Yamada et al., 2003; Li et al., 2008; Oishi et al., 2012; Wang et al., 2013) . The differences in BMD among different genotypes for the distal radius had no statistical significance. This was not similar to the results from Ni et al. (2014) , who found a significant association between the -634C/G polymorphism and distal radius BMD in an Asian population. All the data showed that the genetic influence of the -634C/G SNP on BMD may have site-specific skeletal character. However, there are some limitations to our research. Firstly, the eligible articles we retrieved were all from Asian countries, which may result in publication bias. Therefore, further studies should be conducted that include other populations to further confirm the conclusions from this study. Second, every included study has its own design characteristics and other influencing factors including diet, lifestyle, environment and genetic factors were not taken into account. Finally, the number of eligible studies and sample size were small and the reliability of the conclusions remains to be further optimized.
Until now, the involvement of IL-6 in the occurrence of OP has remained unclear. IL-6 expression increases in patients with OP, which has been regarded as a candidate gene regulating bone mineral density (Inada and Miyaura, 2010) . IL-6 is synthesized from osteoblasts and is a bone restorative cytokine. It can promote the proliferation and differentiation of precursor cells, stimulate the aggregation of osteoclasts, and inhibit the apoptosis of osteoclasts (Bakker et al., 2014) . In addition, estrogen can inhibit the synthesis of IL-6 in osteoblasts and affect the intracellular signal transduction of IL-6, which regulates IL-6 bone resorption activity (Garnero et al., 2002) . Therefore, the role of IL-6 in OP mainly depends on mediating estrogen pathways to cause bone loss.
